Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
about
Clinical implications of BRAF mutation test in colorectal cancer.BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsAnalysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profilingOncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndromeCurrent approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patientsB vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancerMutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA.Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current StatusCpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer.Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsThe GIST paradigm: lessons for other kinase-driven cancers.Serrated polyps: critical precursors to colorectal cancer.Serrated polyposis syndrome: molecular, pathological and clinical aspects.The third dimension: new developments in cell culture models for colorectal research.Dietary DHA and health: cognitive function ageing.Dietary DHA, bioaccessibility, and neurobehavioral development in children.Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients.BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.Sensitive High-Resolution Melting Analysis for Screening of KRAS and BRAF Mutations in Iranian Human Metastatic Colorectal CancersBRAF mutation-specific promoter methylation of FOX genes in colorectal cancerEndoscopic Observation of the Growth Process of a Right-Side Sessile Serrated Adenoma/Polyp with Cytological Dysplasia to an Invasive Submucosal Adenocarcinoma.V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?In situ validation of an intestinal stem cell signature in colorectal cancer.Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.A significant imbalance in mitosis versus apoptosis accelerates the growth rate of sessile serrated adenoma/polyps.Seafood lipids and cardiovascular health
P2860
Q27692120-94FAF250-4DBD-477B-B0AA-0F22191BFF8AQ28543370-9A37B64D-4ECC-432D-9FBA-FA5BFE900F25Q33520213-76AD3379-9C17-4977-BBE7-577C8FAD21BCQ33581231-D1221407-70EF-42CB-A7C0-A323619AFD5EQ33828527-F606BDC7-A0BA-480F-973F-BA45631855A6Q33861210-2F759F0B-A8C5-4EDD-A1C7-B845CFD756BFQ33954696-04C16CF5-ED80-4895-AA27-E715F8E93AEAQ33988695-FAB084B5-CE4B-493B-86B7-5E823A9E9998Q34358286-23DF821D-8F0A-48B3-80A9-CCB03AB86850Q34976598-300A29B5-B374-4993-88FA-C11D20F7BD1DQ34976621-E3B33B1B-B1EF-4D33-82F7-B9504868D6E1Q36075933-133F53D7-D5F5-431F-8090-22B802FD7BE8Q36890349-D8909818-F97A-4694-8288-827F241909E9Q37210779-02E7FE5B-7627-4AA1-ADB0-48B83E8FBF36Q37327430-E773F5F8-C2A0-40B8-8AA1-5E887D4FF8CCQ37815140-22963E30-ACFC-41B8-A695-9DA4F9DB2DCDQ37930647-F7D1FD67-F4E9-4D4D-A631-998A6BD8E039Q38015332-59AFFDBD-9BE1-4786-8DF4-F5D91DA80249Q38773122-17822216-4B88-48CB-873D-6D5CF443738EQ39014590-25191146-8285-435D-A313-BAC5530B7896Q39407110-44802BC2-DDE3-4067-B0A5-B05B4AE0A177Q39456150-A6940DD6-8FA1-40A1-96DE-BC90684F8948Q40031893-AC0D37FC-A0DB-42E8-851F-373349E6ADECQ40364772-3C72E7D7-4574-4AF8-BB6D-4C2A7FBB68ABQ41056167-7ADB5202-6D53-4BA8-8EB7-4B8793621609Q41761875-6D5A214D-3F30-4E4D-B685-2D65B7B70954Q42059658-23D2991A-DB4E-430C-A8B8-8469F0FFC135Q42947711-9855DC7A-4031-4DB0-A0DA-BE57FB5EECC7Q46080136-CDAF9780-C6F9-4ABA-9FFB-D397E7779E52Q48126035-5043374B-A584-480C-9E33-864D22A381E5Q52336141-FDA0ED3A-E385-4458-8A71-146A0CC37573Q53126217-7C2BD12C-9EE6-4CFC-9B6A-0FF74BD18678Q58230524-AEDB7186-7E30-4474-AF77-93DAA143540C
P2860
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
@en
type
label
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
@en
prefLabel
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
@en
P2093
P2860
P356
P1476
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
@en
P2093
P2860
P304
P356
10.1002/PATH.2160
P577
2007-06-01T00:00:00Z